You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ASND Buy Disclosure
Smith Scott Thomas · SEC Form 4 · Filed Jun 2, 2026
Buy
Calculated transaction value
$21.9K
Smith Scott Thomas EVP & Chief Financial Officer
ASND
Transaction date
Jun 2, 2026
Public filing date
Jun 2, 2026
Filing lag
Filed same day
ASND daily price context
Close on/before transaction
$216.6
Jun 2, 2026
First close after public filing
$216.79
Jun 3, 2026
30-day return after filing
+26.62%
Through Jul 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 100 shares @ $219
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001610717-26-000179
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$21.9K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ascendis Pharma A/s ASND Current | Buy | Jun 2, 2026 | $21.9K |